Chair Designate

Source: RNS
RNS Number : 9946T
Essentra plc
01 July 2024
 

1 July 2024

ESSENTRA PLC

("Essentra")

 

STEVE GOOD, CHAIR DESIGNATE - commencement of appointment

 

Essentra plc, a leading global provider of essential components and solutions, is delighted to confirm that further to the announcement on 23 May 2024, Steve Good has commenced his appointment as independent Non-Executive Chair Designate with effect from today, 1 July 2024.

Steve will now undergo an extensive induction, visiting Essentra's global facilities and meeting the teams as part of a four-month handover period during which Paul Lester will remain as Chair, standing down on 1 November 2024.

 

For further information please contact:

Essentra plc

Scott Fawcett, Chief Executive

Emma Reid, Company Secretary

 

Tel: +44 (0)1908 359100

FTI Consulting

Richard Mountain

Ariadna Peretz

FTI_essentra@fticonsulting.com

Tel: +44 (0)20 3727 1340

 

 

 

LEI: 5493007MOZNA03BVNE96

 

 




 

Notes to Editors

About Essentra plc

Essentra plc is a FTSE 250 company and a leading global provider of essential components and solutions, focusing on the manufacture and distribution of plastic injection moulded, vinyl dip moulded and metal items.

Headquartered in the United Kingdom, Essentra's global network extends to 28 countries worldwide and includes c.3,000 employees, 14 manufacturing facilities, 24 distribution centres and 33 sales & service centres serving c.69,000 customers with a rapid supply of low cost but essential products for a variety of applications in industries such as equipment manufacturing, automotive, fabrication, electronics, medical and renewable energy.

For further information, please visit www.essentraplc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPPPUUAQUPCGUQ